Related Experiment Video
Updated: Jun 25, 2026
16:18
Microfluidic Device for Recreating a Tumor Microenvironment in Vitro
Published on: November 20, 2011
A multipurpose microfluidic device designed to mimic microenvironment gradients and develop targeted cancer
Colin L Walsh1, Brett M Babin, Rachel W Kasinskas
1Department of Chemical Engineering, University of Massachusetts, 159 Goessmann Laboratory, 686 North Pleasant Street. Amherst, MA 01003-9303, USA.
Lab on a Chip
|February 5, 2009
Summary
Researchers developed a microfluidic device to mimic tumor microenvironments, enabling better cancer drug development and testing for improved therapeutic efficacy in solid tumors.
Area of Science:
- Biomedical Engineering
- Cancer Research
- Microfluidics
Background:
- Tumor microenvironment heterogeneity significantly impacts cancer therapy effectiveness.
- Developing in vitro models that replicate in vivo tumor conditions is crucial for advancing cancer treatment strategies.
Purpose of the Study:
- To design and validate a microfluidic device that accurately mimics tumor microenvironment gradients.
- To provide a platform for studying drug penetration and efficacy in a controlled, tumor-like setting.
Main Methods:
- Fabrication of a microfluidic device with micron-scale chambers and medium perfusion to establish nutrient gradients.
- Utilizing quantitative transmitted and fluorescence microscopy for analyzing cell mass regions.
- Employing time-lapse microscopy for growth rate assessment and long-term efficacy studies.
Main Results:
- The device successfully created linear nutrient gradients and mimicked viable, apoptotic, and acidic regions found in vivo.
- Accurate measurement of doxorubicin diffusion coefficients and quantification of therapeutic bacteria accumulation were achieved.
- Demonstrated the device's utility for long-term cancer therapy efficacy studies.
Conclusions:
- The developed microfluidic device serves as a vital tool for understanding cancer drug behavior in solid tumors.
- This platform facilitates the design of novel, intratumorally targeted therapeutics by simulating critical microenvironment factors.
